Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,122.86
+2,793.88(+5.90%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Enlivex Therapeutics Ltd. (ENLV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.6200

0.0000

(0.00%)

At close: 04:00PM EDT

1.5500

-0.07

(-4.32%)

After hours:

04:27PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	30.85M
Enterprise value	4.56M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	1.03
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-0.19

Trading information

Stock price history

Beta (5Y monthly)	1.05
52-week change ³	-40.88%
S&P500 52-week change ³	22.43%
52-week high ³	4.5900
52-week low ³	1.1500
50-day moving average ³	3.0111
200-day moving average ³	2.4035

Share statistics

Avg vol (3-month) ³	184.13k
Avg vol (10-day) ³	139.1k
Shares outstanding ⁵	18.81M
Implied shares outstanding ⁶	18.81M
Float ⁸	14.55M
% held by insiders ¹	11.67%
% held by institutions ¹	8.93%
Shares short (15 Apr 2024) ⁴	278.65k
Short ratio (15 Apr 2024) ⁴	0.87
Short % of float (15 Apr 2024) ⁴	1.58%
Short % of shares outstanding (15 Apr 2024) ⁴	1.48%
Shares short (prior month 15 Mar 2024) ⁴	261.46k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	06 Mar 2019
Ex-dividend date ⁴	N/A
Last split factor ²	1:8
Last split date ³	06 Mar 2019

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-30.09%
Return on equity (ttm)	-66.88%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-24.32M
Net income avi to common (ttm)	-29.07M
Diluted EPS (ttm)	-1.5600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	27.32M
Total cash per share (mrq)	1.47
Total debt (mrq)	1.03M
Total debt/equity (mrq)	3.43%
Current ratio (mrq)	5.57
Book value per share (mrq)	1.62

Cash flow statement

Operating cash flow (ttm)	-23.52M
Levered free cash flow (ttm)	-17.77M